Clinical trial
A Multicentre, Natural History, Non-interventional Study Evaluating Biomarkers In Participants With Geographic Atrophy(GA) Secondary To Age-Related Macular Degeneration (AMD)
NCT05797896 is registered in ClinicalTrials.gov with Complement Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicentre, Natural History, Non-interventional Study Evaluating Biomarkers In Participants With Geographic Atrophy(GA) Secondary To Age-Related Macular Degeneration (AMD)
- Lead sponsor
- Complement Therapeutics
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- February 7, 2023
- Completion date
- July 31, 2027
- Enrollment
- 250 (estimated)
- Sites
- 22
Conditions
As the registry lists them; a condition with its own page is linked.
dry age-related macular degeneration, eye diseases, geographic atrophy, macular atrophy, macular degeneration, retinal degeneration, retinal disease